India is expected to grant indemnity to Pfizer and Moderna against legal proceedings, along the lines of what has been granted to them in other countries, according to sources quoted by the media on Wednesday.
Health ministry sources said that the indemnity against liability requested by the two vaccine manufacturers should not be a major issue, as the US and other countries are also operating with the same agreement.
However, the government wants the two companies to apply for emergency use authorisation in India.
Both Pfizer and Moderna have been insisting on indemnity in India, just as they have sought in other countries where they supply vaccines.
Pfizer is expected to start supplying vaccines to India in tranches of 10 million from July, once it gets the indemnity.
A company spokesperson told the media that there were ongoing discussions with the government.
“As we have maintained all along, during the pandemic phase, Pfizer will supply the Covid-19 vaccine only to central governments and supra-national organisations for deployment in national immunisation programmes,” said the spokesperson.
“The allocation of doses and implementation plan within a country is a decision for local governments based on relevant health authority guidelines.”
The competition will be a key highlight of the third edition of the 1 Billion Followers Summit, taking place from January 11 to 13, 2025
The event featured insights from key speakers, including Yogacharya Dhakaram, Nilesh Ashar, and Ekansh Agrawal.
The first two Tests will be held back-to-back in Multan and the last in Rawalpindi
They will remain on display at the museum until at least April 2025
Unveil four prestigious 'Majors' in Men’s and Ladies’ Divisions to secure premier invitations for the elite tournaments
The organisation was honoured during a glittering award ceremony at ASCM Connect 2024: North America in Austin, Texas
The Numaish Festive Edit 2024 will showcase an impressive array of over 90 exclusive designers